Steel Peak Wealth Management LLC Crispr Therapeutics Ag Transaction History

Steel Peak Wealth Management LLC

$2.85 Billion
Q3 2025

A detailed history of Steel Peak Wealth Management LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Steel Peak Wealth Management LLC holds 8,937 shares of CRSP stock, worth $494,394. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,937

Previous 8,543 4.61%

Holding current value

$494,394

Previous $415,000 39.52%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 21, 2025	BUY	$48.51 - $68.14 $19,112 - $26,847	394 Added 4.61%	8,937 $579,000
Q2 2025 Jul 22, 2025	SELL	$31.27 - $48.64 $9,943 - $15,467	-318 Reduced 3.59%	8,543 $415,000
Q1 2025 Apr 30, 2025	BUY	$34.03 - $53.02 $96,645 - $150,576	2,840 Added 47.17%	8,861 $301,000
Q4 2024 Jan 22, 2025	SELL	$38.65 - $55.15 $160,861 - $229,534	-4,162 Reduced 40.87%	6,021 $236,000
Q3 2024 Oct 25, 2024	SELL	$44.62 - $62.75 $244,383 - $343,681	-5,477 Reduced 34.97%	10,183 $478,000

Q2 2024 Jul 16, 2024	BUY	$51.17 - $68.18 $276,676 - $368,649	5,407 Added 52.74%	15,660 $845,000
Q1 2024 Apr 17, 2024	BUY	$60.67 - $89.12 $350,915 - $515,470	5,784 Added 129.42%	10,253 $698,000
Q4 2023 Jan 23, 2024	SELL	$38.62 - $72.18 $50,630 - $94,627	-1,311 Reduced 22.68%	4,469 $279,000
Q3 2023 Nov 02, 2023	BUY	$45.39 - $59.0 $33,361 - $43,365	735 Added 14.57%	5,780 $262,000
Q2 2023 Aug 02, 2023	SELL	$43.47 - $67.77 $189,790 - $295,883	-4,366 Reduced 46.39%	5,045 $283,000
Q1 2023 May 05, 2023	BUY	$41.0 - $56.12 $111,930 - $153,207	2,730 Added 40.86%	9,411 $425,000
Q4 2022 Jan 25, 2023	BUY	$39.19 - $65.67 $27,707 - $46,428	707 Added 11.83%	6,681 $0
Q3 2022 Oct 26, 2022	SELL	$61.1 - $83.78 $80,346 - $110,170	-1,315 Reduced 18.04%	5,974 $390,000
Q2 2022 Aug 02, 2022	SELL	$43.23 - $73.83 $281,600 - $480,928	-6,514 Reduced 47.19%	7,289 $443,000
Q1 2022 May 10, 2022	BUY	$53.19 - $79.24 $109,358 - $162,917	2,056 Added 17.5%	13,803 $867,000
Q4 2021 Jan 31, 2022	BUY	$70.09 - $111.29 $384,653 - $610,759	5,488 Added 87.68%	11,747 $890,000
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $280,238 - $398,335	2,543 Added 68.43%	6,259 $701,000
Q2 2021 Aug 13, 2021	BUY	$100.84 - $161.89 $111,428 - $178,888	1,105 Added 42.32%	3,716 $602,000
Q1 2021 May 18, 2021	BUY	$110.72 - $210.04 $289,089 - $548,414	2,611 New	2,611 $318,000

Others Institutions Holding CRSP

# of Institutions

547

Shares Held

67.6M

Call Options Held

3.5M

Put Options Held

3.08M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.32B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steel Peak Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steel Peak Wealth Management LLC with notifications on news.

Account

Steel Peak Wealth Management LLC Crispr Therapeutics Ag Transaction History